Skip to content

AACR-Kids Beating Cancer Margaret Guedes Monosomy 7 Legacy Cancer Research Grant

Medicine, Genetics and Pharmacology research grant from American Association for Cancer Research

Apply by Tuesday, Dec 1

Up to $300,000
Apply on funder site (opens in a new tab)

About

Support basic, translational, clinical or population research on monosomy 7 AML and other rare, high-risk cytogenetic AML subtypes. Projects should address mechanisms, therapeutic vulnerabilities, biomarkers, treatment response, relapse or survivorship, producing useful diagnostic, therapeutic or trial-enabling findings. The three-year term begins 1 April 2027. Applications are due 1 December 2026 at 13:00 U.S. Eastern Time.

Eligibility

Career stage: Not stated

Apply directly

Covers: USD 300,000 over three years.

Host location: Worldwide

Academic, medical or research institution worldwide; U.S. federal government and for-profit employment excluded.

Nationality or residence: No citizenship restriction.

Eligibility source

Reviewed Oct 12, 2026. Check the funder’s full conditions before applying.

Related doctoral degree and independent, non-mentored research position by 1 April 2027. Academic, medical or research host worldwide; work status must cover the term. Active AACR membership required by submission. No further doctoral candidature, U.S. federal or for-profit employment, or overlapping AACR grant.

Topics

monosomy 7 AMLhigh-risk cytogenetic AML subtypesmechanismstherapeutic vulnerabilitiesbiomarkerstreatment responserelapsesurvivorship

Related funding

Open funding in Medicine

All funding

Source: aacr.org

We use cookies for analytics.